QQQ1.20%

Trending

BTC2.56%

Info

Home SymbolAPYX

Exchange: NASDAQ·Updated 07:30 PM EST

APYX Apyx Medical Corp

$2.81

$0.08

(2.77%)

Today

Closed $2.81

$0.00

(0.00%)

After Hours

Reported EarningsNov 5

Mkt Cap$121.74M

Vol43,009.00

About APYX

Apyx Medical Corp. operates as an energy-based medical technology company. The firm engages in developing, manufacturing, and marketing a range of electrosurgical products and technologies, as well as related medical products used by the offices of doctors, surgery centers, and hospitals worldwide. It operates through the following segments: Surgical Aesthetics and Original Equipment Manufacturer (OEM). The Surgical Aesthetics segment consists of the Helium Plasma Technology lines, which include Renuvion and J-Plasma. The OEM segment focuses on designing, development, and manufacturing electrosurgical equipment and medical devices by producing generators, medical devices and related accessories. The company was founded by Andrew Makrides in 1978 and is headquartered in Clearwater, FL.

Fundamentals

Mkt Cap

$121.74M

52W High

$5.08

52W Low

$2.25

PE Ratio

-14.52

Avg. Volume

122,761.15

EPS (Annual)

-$0.2728

Rev/Employee

$257,775.61

Earnings

Nov 05

Neutral Sentiment

How do you feel about APYX?

PLATINUM_TRADES

Nov 6

$APYX There u go breaking now.. Overnight swing winner makes this 25 straight winners... $3.28 To break for more 🚨 🚨

PennySearch

Nov 5

📊 Today's Highest Relative Volume $APYX — 650.92x RVOL Move: +19% Volume: 540.9K (152.4K average) Market Cap: $129.7M $ARQ — 115.28x RVOL Move: +29% Volume: 5.1M (258.3K average) Market Cap: $104.0M $DH — 91.78x RVOL Move: +1% Volume: 509.5K (436.9K average) Market Cap: $131.5M High relative volume highlights where market attention is concentrated. Which one are you watching? 👀 Not financial advice.

StocktwitsEarnings

Nov 5

$APYX Q3 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.04 up 20.00% YoY • Reported revenue of $14.03M up 8.93% YoY • Apyx Medical reaffirmed FY2026 revenue guidance of $59M to $60M, expects gross margins of 63% to 65%, and lowered operating expense guidance to $41M to $42.5M from less than $45M.